Ulrich Otte is Senior Vice President, Finance & Operations for
Novo Nordisk Inc. since September 1, 2020. In this role, Mr. Otte
provides strategic direction, business insights and corporate
governance counsel, and now oversees Commercial Operations, to guide
the financial health and commercial execution of the organization.
Joining the U.S. leadership team in 2017, his team has been
responsible for supply chain management, procurement and business
services, pricing and contract operations, information technology, and
commercial effectiveness and data analysis functions. Now, in addition
to his financial management responsibilities, he leads an operational
team focused on the organization’s efforts to unify operational
expertise, drive synergies with Insights & Analytics and IT and
increase adoption of technology.
Mr. Otte brings more than 20 years of broad finance and business
background ranging from technical accounting and auditing, to managing
global transformation projects and leading roles in productions,
commercial and Market Access functions.
Prior to joining Novo Nordisk Inc., Mr. Otte was Corporate Vice
President, Finance for Novo Nordisk China, leading a diverse team that
supported market access, government and public affairs, finance,
information technology and procurement, and Hong Kong commercial operations.
Mr. Otte joined Novo Nordisk in 2000 as Financial Controller
Corporate Accounting in Copenhagen, Denmark and held roles of
increasing financial responsibility in Copenhagen including Corporate
Vice President, Product Supply Global Investment and Finance, and
Corporate Vice President, Corporate Financial Planning. He began his
career as an Audit Manager at PricewaterhouseCoopers.
Mr. Otte holds a Master of Science in Business, Economics and
Auditing from Copenhagen Business School.